Review



anti rac2 mouse monoclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Proteintech anti rac2 mouse monoclonal antibody
    Chemokine-coupled β 2 integrin engagement drives <t>Rac2</t> activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Anti Rac2 Mouse Monoclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/RAC2+Antibody/pmc04172219-90-0-7
    Average 94 stars, based on 29 article reviews
    anti rac2 mouse monoclonal antibody - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Chemokine-coupled β 2 integrin–induced macrophage Rac2–Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis"

    Article Title: Chemokine-coupled β 2 integrin–induced macrophage Rac2–Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis

    Journal: The Journal of Experimental Medicine

    doi: 10.1084/jem.20132130

    Chemokine-coupled β 2 integrin engagement drives Rac2 activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Figure Legend Snippet: Chemokine-coupled β 2 integrin engagement drives Rac2 activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Techniques Used: Activation Assay, Translocation Assay, Western Blot, Control, Expressing, Immunostaining, Quantitative RT-PCR

    Chemokine-coupled integrin-driven activation of Rac2 leads to a unique Rac2-Myh9 complex that correlates with HuR translocation, and in vivo neovascular responses depend on efficient integrin activation of Rac2. (A) THP-1 cells in the presence or absence of CCL2 (50 ng/ml × 10 min) were lysed and GTPγS (or vehicle control)-loaded, followed by PBD affinity pulldown and Coomassie staining (top) or immunoblotting for the indicated Rho family GTPases (bottom; n = 3). (B) Chemokine stimulation and GTP loading as in A, in Rac2 +/+ or Rac2 −/− BMDMs, followed by PBD affinity pulldown and Coomassie staining for the 226 kD protein noted above ( n = 3). (C) Immunoblots from lysates of Rac2 +/+ and Rac2 −/− BMDMs, which were CCL2-treated for 10 min, GTPγS (100 µM)-loaded for 10 min, and affinity precipitated with PBD beads to determine the association of Myh9 with the indicated Rac proteins ( n = 4). (D) Confocal micrographs of human peripheral blood monocytes adhered to ICAM-1 or Fcγ fragment control in the presence or absence of 50 ng/ml CCL2 for 10 min, followed by PLA reaction for Rac2–Myh9 interaction (red signal) and DAPI (cyan) staining ( n = 3). Bar, 15 µm. (E) PLA-HuR translocation correlation graph. THP-1 HuR-YFP stable transfectants were ICAM-1– or poly- l -lysine control-bound in the presence or absence of CCL2, after which PLA and HuR translocation analysis were performed ( r = 0.9, P < 0.0001, n = 3). (F) Rac2 and Myh9 immunoblots from lysates of Rac2 +/+ or Rac2 +/− BMDMs adhered to immobilized ICAM-1 in the presence of 50 ng/ml CCL2, after which Rac2 was affinity precipitated by PBD pulldown ( n = 3). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Rac2 +/+ and Rac2 +/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0025; n = 10). (I) Quantification of CD11b hi F4/80 hi macrophages isolated from collagenase-treated ischemic muscle tissue at day 3 after femoral artery ligation (**, P < 0.0001; n = 6). Animal data are from 2 independent experiments, each with 3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Figure Legend Snippet: Chemokine-coupled integrin-driven activation of Rac2 leads to a unique Rac2-Myh9 complex that correlates with HuR translocation, and in vivo neovascular responses depend on efficient integrin activation of Rac2. (A) THP-1 cells in the presence or absence of CCL2 (50 ng/ml × 10 min) were lysed and GTPγS (or vehicle control)-loaded, followed by PBD affinity pulldown and Coomassie staining (top) or immunoblotting for the indicated Rho family GTPases (bottom; n = 3). (B) Chemokine stimulation and GTP loading as in A, in Rac2 +/+ or Rac2 −/− BMDMs, followed by PBD affinity pulldown and Coomassie staining for the 226 kD protein noted above ( n = 3). (C) Immunoblots from lysates of Rac2 +/+ and Rac2 −/− BMDMs, which were CCL2-treated for 10 min, GTPγS (100 µM)-loaded for 10 min, and affinity precipitated with PBD beads to determine the association of Myh9 with the indicated Rac proteins ( n = 4). (D) Confocal micrographs of human peripheral blood monocytes adhered to ICAM-1 or Fcγ fragment control in the presence or absence of 50 ng/ml CCL2 for 10 min, followed by PLA reaction for Rac2–Myh9 interaction (red signal) and DAPI (cyan) staining ( n = 3). Bar, 15 µm. (E) PLA-HuR translocation correlation graph. THP-1 HuR-YFP stable transfectants were ICAM-1– or poly- l -lysine control-bound in the presence or absence of CCL2, after which PLA and HuR translocation analysis were performed ( r = 0.9, P < 0.0001, n = 3). (F) Rac2 and Myh9 immunoblots from lysates of Rac2 +/+ or Rac2 +/− BMDMs adhered to immobilized ICAM-1 in the presence of 50 ng/ml CCL2, after which Rac2 was affinity precipitated by PBD pulldown ( n = 3). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Rac2 +/+ and Rac2 +/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0025; n = 10). (I) Quantification of CD11b hi F4/80 hi macrophages isolated from collagenase-treated ischemic muscle tissue at day 3 after femoral artery ligation (**, P < 0.0001; n = 6). Animal data are from 2 independent experiments, each with 3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Techniques Used: Activation Assay, Translocation Assay, In Vivo, Control, Staining, Western Blot, Ligation, Isolation

    Macrophage HuR translocation with consequent VEGF-A mRNA stabilization, flow recovery during hind limb ischemia, and tissue VEGF-A mRNA levels depend on myeloid Myh9. (A) Myh9, Actin, Rac2, and CCR2 immunoblots of lysates obtained from BMDMs isolated from LysM +/cre Myh9 +/+ ( Myh9 +/+ ), LysM +/cre Myh9 +/fl ( Myh9 +/− ), and LysM +/cre Myh9 fl/fl ( Myh9 −/− ) mice ( n = 3). (B) Flow cytometric CD11b and Ly6C phenotyping (top) of density gradient–enriched peripheral blood mononuclear cells obtained from myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (lower panel, n = 4). (C) Flow cytometric CD11b and F4/80 phenotyping (top) of cells recovered from the peritoneal cavity 3 d after initiation of thioglycollate-induced peritonitis in myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (bottom, n = 5). (D) Confocal micrographs of Myh9 +/− and Myh9 −/− BMDMs, CCL2-stimulated and ICAM-bound, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin (time 0), and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Myh9 +/− and Myh9 −/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0006; n = 7). (I) Real-time PCR quantification of VEGF-A mRNA in thigh (adductor) muscle tissue obtained 3 d after femoral artery ligation (**, P = 0.003; n = 4). Animal data are from 3 independent experiments, each with 2–3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Figure Legend Snippet: Macrophage HuR translocation with consequent VEGF-A mRNA stabilization, flow recovery during hind limb ischemia, and tissue VEGF-A mRNA levels depend on myeloid Myh9. (A) Myh9, Actin, Rac2, and CCR2 immunoblots of lysates obtained from BMDMs isolated from LysM +/cre Myh9 +/+ ( Myh9 +/+ ), LysM +/cre Myh9 +/fl ( Myh9 +/− ), and LysM +/cre Myh9 fl/fl ( Myh9 −/− ) mice ( n = 3). (B) Flow cytometric CD11b and Ly6C phenotyping (top) of density gradient–enriched peripheral blood mononuclear cells obtained from myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (lower panel, n = 4). (C) Flow cytometric CD11b and F4/80 phenotyping (top) of cells recovered from the peritoneal cavity 3 d after initiation of thioglycollate-induced peritonitis in myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (bottom, n = 5). (D) Confocal micrographs of Myh9 +/− and Myh9 −/− BMDMs, CCL2-stimulated and ICAM-bound, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin (time 0), and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Myh9 +/− and Myh9 −/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0006; n = 7). (I) Real-time PCR quantification of VEGF-A mRNA in thigh (adductor) muscle tissue obtained 3 d after femoral artery ligation (**, P = 0.003; n = 4). Animal data are from 3 independent experiments, each with 2–3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Techniques Used: Translocation Assay, Western Blot, Isolation, Cell Counting, Immunostaining, Control, Quantitative RT-PCR, Ligation, Real-time Polymerase Chain Reaction

    Related Articles

    other:

    Article Title: The Actin Regulatory Protein HS1 Interacts with Arp2/3 and Mediates Efficient Neutrophil Chemotaxis
    Article Snippet: Mouse anti-Rac2 (Proteintech Group), mouse anti-Vav1 clone B-6 (Santa Cruz Biotechnology), rabbit anti-phospho-Vav1(Y174) (Epitomics), goat anti-rabbit Alexa Fluor 680, goat anti-mouse Alexa Fluor 800, mouse anti-GFP (Invitrogen).

    Article Title: The Actin Regulatory Protein HS1 Interacts with Arp2/3 and Mediates Efficient Neutrophil Chemotaxis
    Article Snippet: Mouse anti-Rac2 (Proteintech Group), mouse anti-Vav1 clone B-6 (Santa Cruz Biotechnology), rabbit anti-phosphoVav1(Y174) (Epitomics), goat anti-rabbit Alexa Fluor 680, goat anti-mouse Alexa Fluor 800, mouse anti-GFP (Invitrogen).



    Similar Products

    86
    Danaher Inc rac2 abcam ab191527 alexa fluor 647 anti mouse cd107a
    Rac2 Abcam Ab191527 Alexa Fluor 647 Anti Mouse Cd107a, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/pmc09374378__jci___132___153619___s061-67-102-103
    Average 86 stars, based on 1 article reviews
    rac2 abcam ab191527 alexa fluor 647 anti mouse cd107a - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Millipore mouse anti-rac2 antibodies
    Mouse Anti Rac2 Antibodies, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/anti+rac2+antibody/pmc03800072-40-6-11
    Average 90 stars, based on 1 article reviews
    mouse anti-rac2 antibodies - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    94
    Proteintech anti rac2 mouse monoclonal antibody
    Chemokine-coupled β 2 integrin engagement drives <t>Rac2</t> activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Anti Rac2 Mouse Monoclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/RAC2+Antibody/pmc04172219-90-0-7
    Average 94 stars, based on 1 article reviews
    anti rac2 mouse monoclonal antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Abnova mouse anti-rac2
    Chemokine-coupled β 2 integrin engagement drives <t>Rac2</t> activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Mouse Anti Rac2, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/mouse+anti+rac2/pm22136506-58-26-28
    Average 90 stars, based on 1 article reviews
    mouse anti-rac2 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    94
    Proteintech mouse anti rac2
    Chemokine-coupled β 2 integrin engagement drives <t>Rac2</t> activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.
    Mouse Anti Rac2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/RAC2+Antibody/pmc03408136-48-0-2
    Average 94 stars, based on 1 article reviews
    mouse anti rac2 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit polyclonal anti rac2 antibody
    FIG. 7. LXA4 inhibits P. gingivalis-induced activation of <t>Rac2</t> and Cdc42 in neutrophils. Neutrophils (5 106/sample) were preincubated in the absence or presence of 5 nM LXA4 for 5 min at 37°C and stimulated with P. gingivalis (6 105 CFU/ml) for various times as indicated in the figure. The stimulation was stopped, and activated forms of Rac2 and Cdc42 were precipitated from the lysates using a GST pulldown assay. (A) Neutrophils were stimulated by P. gingivalis for 0.5, 3, and 10 min with and without preincubation with LXA4, a GST pulldown assay was performed with beads lacking the GST-PBD (Neg; negative control), or neutrophils were incubated at 0 or 37°C (basal level). (B) Neutrophils were stimulated with fMLF plus GTPS (Pos; positive control) or whole-cell lysate (Wc; positive control), or a GST-pulldown assay was performed with beads lacking the GST-PBD (Neg; negative control). An equivalent volume was loaded in each lane, and the electrophoretically separated proteins were detected with Western blotting using a <t>polyclonal</t> rabbit anti-human Rac2 antibody (1:200) and a mouse monoclonal anti-human Cdc42 antibody (1:250), clone 44.
    Rabbit Polyclonal Anti Rac2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+rac2/mouse+anti-rabbit+IgG-FITC/10__1128_slash_iai__00777___10-130-36-43
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal anti rac2 antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    Chemokine-coupled β 2 integrin engagement drives Rac2 activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Journal: The Journal of Experimental Medicine

    Article Title: Chemokine-coupled β 2 integrin–induced macrophage Rac2–Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis

    doi: 10.1084/jem.20132130

    Figure Lengend Snippet: Chemokine-coupled β 2 integrin engagement drives Rac2 activation (GTP-loading), Rac2-dependent HuR translocation, and consequent VEGF mRNA stabilization. (A) Rac2 and Myh9 immunoblots from lysates of WT BMDMs adhered to immobilized ICAM-1 or Fcγ fragment control for 5 min at 37°C in the presence or absence of 50 ng/ml CCL2, after which GTP-Rac2 was affinity precipitated by PBD pulldown ( n = 4). (B) Rac2, Myh9, Actin, and CCR2 immunoblots from lysates of Rac2 +/+ , Rac2 +/− , and Rac2 −/− BMDMs ( n = 3). (C) Relative CCR2 surface expression on thioglycollate-elicited peritoneal macrophages (CD11b hi F4/80 hi ) from Rac2 +/+ (red) and Rac2 −/− (blue) mice (isotype control; black, n = 4). (D) Confocal micrographs of Rac2 +/+ and Rac2 −/− BMDMs, CCL2-stimulated and ICAM-bound for 30 min, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin d at time 0, and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). Thioglycollate-elicited peritoneal macrophage data are from two independent experiments, each with two mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Article Snippet: Anti-Rac2 mouse monoclonal antibody was purchased from Proteintech.

    Techniques: Activation Assay, Translocation Assay, Western Blot, Control, Expressing, Immunostaining, Quantitative RT-PCR

    Chemokine-coupled integrin-driven activation of Rac2 leads to a unique Rac2-Myh9 complex that correlates with HuR translocation, and in vivo neovascular responses depend on efficient integrin activation of Rac2. (A) THP-1 cells in the presence or absence of CCL2 (50 ng/ml × 10 min) were lysed and GTPγS (or vehicle control)-loaded, followed by PBD affinity pulldown and Coomassie staining (top) or immunoblotting for the indicated Rho family GTPases (bottom; n = 3). (B) Chemokine stimulation and GTP loading as in A, in Rac2 +/+ or Rac2 −/− BMDMs, followed by PBD affinity pulldown and Coomassie staining for the 226 kD protein noted above ( n = 3). (C) Immunoblots from lysates of Rac2 +/+ and Rac2 −/− BMDMs, which were CCL2-treated for 10 min, GTPγS (100 µM)-loaded for 10 min, and affinity precipitated with PBD beads to determine the association of Myh9 with the indicated Rac proteins ( n = 4). (D) Confocal micrographs of human peripheral blood monocytes adhered to ICAM-1 or Fcγ fragment control in the presence or absence of 50 ng/ml CCL2 for 10 min, followed by PLA reaction for Rac2–Myh9 interaction (red signal) and DAPI (cyan) staining ( n = 3). Bar, 15 µm. (E) PLA-HuR translocation correlation graph. THP-1 HuR-YFP stable transfectants were ICAM-1– or poly- l -lysine control-bound in the presence or absence of CCL2, after which PLA and HuR translocation analysis were performed ( r = 0.9, P < 0.0001, n = 3). (F) Rac2 and Myh9 immunoblots from lysates of Rac2 +/+ or Rac2 +/− BMDMs adhered to immobilized ICAM-1 in the presence of 50 ng/ml CCL2, after which Rac2 was affinity precipitated by PBD pulldown ( n = 3). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Rac2 +/+ and Rac2 +/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0025; n = 10). (I) Quantification of CD11b hi F4/80 hi macrophages isolated from collagenase-treated ischemic muscle tissue at day 3 after femoral artery ligation (**, P < 0.0001; n = 6). Animal data are from 2 independent experiments, each with 3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Journal: The Journal of Experimental Medicine

    Article Title: Chemokine-coupled β 2 integrin–induced macrophage Rac2–Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis

    doi: 10.1084/jem.20132130

    Figure Lengend Snippet: Chemokine-coupled integrin-driven activation of Rac2 leads to a unique Rac2-Myh9 complex that correlates with HuR translocation, and in vivo neovascular responses depend on efficient integrin activation of Rac2. (A) THP-1 cells in the presence or absence of CCL2 (50 ng/ml × 10 min) were lysed and GTPγS (or vehicle control)-loaded, followed by PBD affinity pulldown and Coomassie staining (top) or immunoblotting for the indicated Rho family GTPases (bottom; n = 3). (B) Chemokine stimulation and GTP loading as in A, in Rac2 +/+ or Rac2 −/− BMDMs, followed by PBD affinity pulldown and Coomassie staining for the 226 kD protein noted above ( n = 3). (C) Immunoblots from lysates of Rac2 +/+ and Rac2 −/− BMDMs, which were CCL2-treated for 10 min, GTPγS (100 µM)-loaded for 10 min, and affinity precipitated with PBD beads to determine the association of Myh9 with the indicated Rac proteins ( n = 4). (D) Confocal micrographs of human peripheral blood monocytes adhered to ICAM-1 or Fcγ fragment control in the presence or absence of 50 ng/ml CCL2 for 10 min, followed by PLA reaction for Rac2–Myh9 interaction (red signal) and DAPI (cyan) staining ( n = 3). Bar, 15 µm. (E) PLA-HuR translocation correlation graph. THP-1 HuR-YFP stable transfectants were ICAM-1– or poly- l -lysine control-bound in the presence or absence of CCL2, after which PLA and HuR translocation analysis were performed ( r = 0.9, P < 0.0001, n = 3). (F) Rac2 and Myh9 immunoblots from lysates of Rac2 +/+ or Rac2 +/− BMDMs adhered to immobilized ICAM-1 in the presence of 50 ng/ml CCL2, after which Rac2 was affinity precipitated by PBD pulldown ( n = 3). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Rac2 +/+ and Rac2 +/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0025; n = 10). (I) Quantification of CD11b hi F4/80 hi macrophages isolated from collagenase-treated ischemic muscle tissue at day 3 after femoral artery ligation (**, P < 0.0001; n = 6). Animal data are from 2 independent experiments, each with 3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Article Snippet: Anti-Rac2 mouse monoclonal antibody was purchased from Proteintech.

    Techniques: Activation Assay, Translocation Assay, In Vivo, Control, Staining, Western Blot, Ligation, Isolation

    Macrophage HuR translocation with consequent VEGF-A mRNA stabilization, flow recovery during hind limb ischemia, and tissue VEGF-A mRNA levels depend on myeloid Myh9. (A) Myh9, Actin, Rac2, and CCR2 immunoblots of lysates obtained from BMDMs isolated from LysM +/cre Myh9 +/+ ( Myh9 +/+ ), LysM +/cre Myh9 +/fl ( Myh9 +/− ), and LysM +/cre Myh9 fl/fl ( Myh9 −/− ) mice ( n = 3). (B) Flow cytometric CD11b and Ly6C phenotyping (top) of density gradient–enriched peripheral blood mononuclear cells obtained from myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (lower panel, n = 4). (C) Flow cytometric CD11b and F4/80 phenotyping (top) of cells recovered from the peritoneal cavity 3 d after initiation of thioglycollate-induced peritonitis in myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (bottom, n = 5). (D) Confocal micrographs of Myh9 +/− and Myh9 −/− BMDMs, CCL2-stimulated and ICAM-bound, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin (time 0), and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Myh9 +/− and Myh9 −/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0006; n = 7). (I) Real-time PCR quantification of VEGF-A mRNA in thigh (adductor) muscle tissue obtained 3 d after femoral artery ligation (**, P = 0.003; n = 4). Animal data are from 3 independent experiments, each with 2–3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Journal: The Journal of Experimental Medicine

    Article Title: Chemokine-coupled β 2 integrin–induced macrophage Rac2–Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis

    doi: 10.1084/jem.20132130

    Figure Lengend Snippet: Macrophage HuR translocation with consequent VEGF-A mRNA stabilization, flow recovery during hind limb ischemia, and tissue VEGF-A mRNA levels depend on myeloid Myh9. (A) Myh9, Actin, Rac2, and CCR2 immunoblots of lysates obtained from BMDMs isolated from LysM +/cre Myh9 +/+ ( Myh9 +/+ ), LysM +/cre Myh9 +/fl ( Myh9 +/− ), and LysM +/cre Myh9 fl/fl ( Myh9 −/− ) mice ( n = 3). (B) Flow cytometric CD11b and Ly6C phenotyping (top) of density gradient–enriched peripheral blood mononuclear cells obtained from myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (lower panel, n = 4). (C) Flow cytometric CD11b and F4/80 phenotyping (top) of cells recovered from the peritoneal cavity 3 d after initiation of thioglycollate-induced peritonitis in myeloid cell–specific Myh9 +/− and Myh9 −/− mice along with quantification of absolute cell count per ml blood (bottom, n = 5). (D) Confocal micrographs of Myh9 +/− and Myh9 −/− BMDMs, CCL2-stimulated and ICAM-bound, followed by HuR immunostaining for translocation analysis. Bar, 10 µm. (E) Quantification of percentage of cells in D with HuR nuclear-to-cytosolic translocation (**, P < 0.002; n = 3). (F) VEGF-A mRNA decay assays, using the indicated BMDMs, adhered to immobilized ICAM-1 or Fcγ fragment control in the presence or absence of CCL2 for 30 min, after which transcription was arrested with 10 mg/ml actinomycin (time 0), and RNA collected at the noted time points for VEGF-A mRNA quantification by RT-qPCR (**, P = 0.0001; n = 5). (G and H) Laser Doppler scan images (G) of flow in the ischemic (I) and contralateral control (C) hind limb of Myh9 +/− and Myh9 −/− mice at the indicated time points before and after femoral artery ligation with quantitative blood flow analysis (H; **, P < 0.0006; n = 7). (I) Real-time PCR quantification of VEGF-A mRNA in thigh (adductor) muscle tissue obtained 3 d after femoral artery ligation (**, P = 0.003; n = 4). Animal data are from 3 independent experiments, each with 2–3 mice per treatment group. Remaining data are representative of at least 3 independent experiments. Quantitative data are displayed as mean ± SEM.

    Article Snippet: Anti-Rac2 mouse monoclonal antibody was purchased from Proteintech.

    Techniques: Translocation Assay, Western Blot, Isolation, Cell Counting, Immunostaining, Control, Quantitative RT-PCR, Ligation, Real-time Polymerase Chain Reaction

    FIG. 7. LXA4 inhibits P. gingivalis-induced activation of Rac2 and Cdc42 in neutrophils. Neutrophils (5 106/sample) were preincubated in the absence or presence of 5 nM LXA4 for 5 min at 37°C and stimulated with P. gingivalis (6 105 CFU/ml) for various times as indicated in the figure. The stimulation was stopped, and activated forms of Rac2 and Cdc42 were precipitated from the lysates using a GST pulldown assay. (A) Neutrophils were stimulated by P. gingivalis for 0.5, 3, and 10 min with and without preincubation with LXA4, a GST pulldown assay was performed with beads lacking the GST-PBD (Neg; negative control), or neutrophils were incubated at 0 or 37°C (basal level). (B) Neutrophils were stimulated with fMLF plus GTPS (Pos; positive control) or whole-cell lysate (Wc; positive control), or a GST-pulldown assay was performed with beads lacking the GST-PBD (Neg; negative control). An equivalent volume was loaded in each lane, and the electrophoretically separated proteins were detected with Western blotting using a polyclonal rabbit anti-human Rac2 antibody (1:200) and a mouse monoclonal anti-human Cdc42 antibody (1:250), clone 44.

    Journal: Infection and Immunity

    Article Title: Lipoxin A 4 Inhibits Porphyromonas gingivalis -Induced Aggregation and Reactive Oxygen Species Production by Modulating Neutrophil-Platelet Interaction and CD11b Expression

    doi: 10.1128/iai.00777-10

    Figure Lengend Snippet: FIG. 7. LXA4 inhibits P. gingivalis-induced activation of Rac2 and Cdc42 in neutrophils. Neutrophils (5 106/sample) were preincubated in the absence or presence of 5 nM LXA4 for 5 min at 37°C and stimulated with P. gingivalis (6 105 CFU/ml) for various times as indicated in the figure. The stimulation was stopped, and activated forms of Rac2 and Cdc42 were precipitated from the lysates using a GST pulldown assay. (A) Neutrophils were stimulated by P. gingivalis for 0.5, 3, and 10 min with and without preincubation with LXA4, a GST pulldown assay was performed with beads lacking the GST-PBD (Neg; negative control), or neutrophils were incubated at 0 or 37°C (basal level). (B) Neutrophils were stimulated with fMLF plus GTPS (Pos; positive control) or whole-cell lysate (Wc; positive control), or a GST-pulldown assay was performed with beads lacking the GST-PBD (Neg; negative control). An equivalent volume was loaded in each lane, and the electrophoretically separated proteins were detected with Western blotting using a polyclonal rabbit anti-human Rac2 antibody (1:200) and a mouse monoclonal anti-human Cdc42 antibody (1:250), clone 44.

    Article Snippet: Unspecific binding was blocked by incubating the membranes in 5% milk-TBS (for 1 h at RT) prior to incubation with the mouse monoclonal anti-Cdc42 antibody (1:250; clone 44; BD Transduction Laboratories, San Diego, CA) or a rabbit polyclonal anti-Rac2 antibody (1:200; clone C-11; Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at RT.

    Techniques: Activation Assay, GST Pulldown Assay, Negative Control, Incubation, Positive Control, Western Blot